Physician Assistants
Christen Kutz, PhD, PA-C
B.A. - Biology; Lehigh University, Bethlehem, PA
M.S. - Physician Assistant Studies; Desales University, Center Valley, PA
DHSc - Doctor of Health Science; Nova Southeastern University, Ft. Lauderdale, FL
PhD - PhD; Nova Southeastern University, Ft. Lauderdale, FL
Christen F. Kutz, PhD, PA-C
Colorado Springs Neurological Associates
Director of Research
2312 N. Nevada Avenue
Colorado Springs, CO 80907
www.csneuro.com
Phone: 719-473-3272
Fax: 719-389-1192
Billy Collins, DHSc, PA-C
Clinical research consultant
Commander (CDR) Billy Collins, DHSc, PA-C is a commissioned officer within the U.S. Public Health Service. He is currently serving as Associate Investigator and Clinic Director within the National Heart, Lung, Blood Institute at NIH. CDR Collins served as Site Director of Research for the Defense & Veterans Brain Injury Center at Fort Bragg, NC where he also functioned as a Principal Investigator and member of the Womack Army Medical Center Institutional Review Board.
Billy earned a Bachelor of Science degree in Respiratory Care from the University of Texas Medical Branch at Galveston, Texas and his Master of Science degree in PA studies at East Carolina University in Greenville, North Carolina. He received a Doctorate of Health Sciences degree from Nova Southeastern University in Fort Lauderdale, Florida.
Susan Symington, MPAS, PA-C, DFAAPA
Susan has been a clinically practicing and certified PA for over 25 years. She has practiced clinically in a wide variety of settings including Family Medicine, Urgent Care/Emergency Medicine, Internal Medicine/Pediatrics, Allergy Asthma and Immunology, and Adult Pulmonary. She has taught in three PA Programs full-time. She was an Assistant Professor at Grand Valley State University and Midwestern University (Glendale, AZ campus) and also an Associate Professor and the Associate Program Director at the University of Washington’s MEDEX Northwest PA Program. She has been a national speaker for PA and NP CME (Continuing Medical Education) conferences for 10 years and has published in peer reviewed PA and NP journals on topics related to Allergy, Asthma, and Immunology. She has been involved with the AAPA for over ten years in different capacities. She is the Immediate Past President for the Association for PAs in Allergy, Asthma and Immunology and served as the AAPA’s medical liaison to the American Academy of Allergy, Asthma and Immunology organization. She has served on the AAPA’s Commission on Continuing Medical Education and Professional Development. Currently, she serves as a trustee for the PA Foundation board of directors.
In 2017, She joined AstraZeneca US Respiratory Medical Affairs as a Respiratory Clinical Science Liaison (CSL). She covered the Pacific Northwest (Washington, Alaska, Oregon and Idaho) and in May, 2019, joined the Cardiovascular Metabolic Disease team as a CSL for the Arizona, New Mexico territory. In July, 2020, Susan joined Genentech Medical Affairs as a Medical Science Liaison (MSL) in Hematology/Rare Blood Disorders/Hemophilia. Entering her fourth year as a science liaison, Susan is the person between the company and the health care provider, who develops relationships and becomes an expert in disease states. She is also an expert in the clinical trials related to the products in development or already FDA approved. She interprets the data from the clinical trials to educate providers on the right patient for the product based on the scientific evidence. She also establishes sites to be involved in clinical trials and gains insights from different stakeholders and organizations. Susan has two adult children who live in Tucson, Arizona. She enjoys spending time with them and also her new puppy, Lily, a white lab. In her spare time she enjoys music, theater, watching sports, and exercising.
Cell: 623-261-9558
Email: susiekpa22@gmail.com
Viet T. Le, MPAS PA-C FACC FAHA
5121 South Cottonwood Dr., Salt Lake City, UT 84107 | 801-507-4907 | Viet.Le@imail.org
EDUCATION
Bachelor of Science
Exercise Science/Athletic Training 1995-2001
Student Health Advisory Committee 1998 to 2000
Student Athletic Trainer over Division I Cross Country and Track & Field
University of Utah, Salt Lake City, UT, USA
Master of Physician Assistant Studies
Physician Assistant 2002-2004
Thesis: Opioid Use in the Primary Care Setting
University of Utah School of Medicine, Salt Lake City, UT, USA
Doctor of Medical Science
Area of Concentration: Health Profession Education 2019-present
Additional certificate: Healthcare Leadership & Administration
Applied Scholarly Project:
Quality Improvement in Cardiovascular Prevention: Focus on Familial Hypercholesterolemia
Rocky Mountain University of Health Professions, Provo, UT, USA
Current RESEARch involvement at Intermountain
1. OMEGA-3 (The relationship between Omega 3 plasma levels and angiographic and clinical cardiovascular risk and clinical safety in the INSPIRE Registry)
Dell Loy Hansen Research Grant Fund, $60,000
o Co-Principal Investigator with Dr. Jeffrey L. Anderson
2. INSPIRE Registry (INtermountain Healthcare Biological Samples Collection Project and Investigational REgistry for the On-going Study of Disease Origin, Progression and Treatment)
Intermountain Healthcare, Intermountain Heart Institute
o Co-Investigator, INSPIRE Registry (formerly IHCS Registry) 2013-current
o Member, INSPIRE Registry Oversight Committee (IOC) 2016-current
a. The Intermountain Spontaneous Coronary Artery Dissection (SCAD) Registry
o Co-Investigator
b. SCAD-INSPIRE Genetics
o Co-Investigator
c. Protective Genes for Coronary Heart Disease (PROGENE): A sub-study of the INSPIRE Registry
o Co-Investigator
3. Assessment of patients with suspeCted Coronary Artery Disease by coronary calciUm fiRst strATegy vErsus usual care approach. A randomized single center study (ACCURATE Study)
o Co-Investigator
4. Impact of Anticoagulation Therapy on the Cognitive Decline and Dementia in Patients with Atrial Fibrillation (CAF Trial)
o Co-Investigator
5. Effectiveness of a Proactive Cardiovascular Primary Prevention Strategy, With or Without the Use of Coronary Calcium Screening, in Preventing Future Major Adverse Cardiac Events (CorCal Study)
o Co-Investigator
6. A Randomized Trial Evaluating Vitamin D Normalization on Major Adverse Cardiovascular-Related Events Among Myocardial Infarction Patients (The TARGET-D Study)
o Co-Investigator
7. PRagmatic EValuation of evENTs And Benefits of Lipid-lowering in oldEr adults (PREVENTABLE)
o Co-Site Investigator
8. Multi-Centre, Multi-National, Open Label, Safety Study of Etripamil Nasal Spray for Patients with Paroxysmal Supraventricular Tachycardia (NODE-303)
o Co-Site Investigator
9. HPS-4/TIMI 65/ORION-4: A double-blind randomized placebo-controlled trial assessing the effects of inclisiran on clinical outcomes among people with atherosclerotic cardiovascular disease
o Co-Site Investigator
10. A long term extension trial of the Phase III lipid-lowering trials to assess the effect of long term dosing of inclisiran given as subcutaneous injections in subjects with high cardiovascular risk and elevated LDL-C (ORION-8)
o Co-Site Investigator
11. Pilot and Feasibility Study of a MAWDS (Medications, Activity, Weight, Diet and Symptoms) Heart Failure Mobile Platform (iMAWDS Mobile HF study)
o Co-investigator
12. Heart Failure Patient-based Simulation Education- Impact on Outcomes (HFSimEd-2 Study)
o Co-Investigator
13. Weekly ONe-Day WatER-only Fasting InterventionaL Trial for Low-Density Lipoprotein Cholesterol Reduction (WONDERFUL)
o Co-Investigator
14. faCTor-64 (Screening For Asymptomatic Obstructive Coronary Artery Disease Among High-Risk Diabetic Patients Using CT Angiography: A Randomized Control Trial)
o Co-Investigator
15. MPI Database (Myocardial perfusion imaging (MPI) database project: the ongoing study of MPI patient population characteristics, MPI assessment, and outcomes.)
o Co-Investigator
16. CV Covid-19 predictors (CV Predictors of COVID-19 positive and severity)
o Co-Investigator
17. ASSESS-D (Acute Effect of Systemic Stress on Measured Blood Concentrations of 25 (OH) Vitamin D)
o Co-Investigator
18. ENCOURAGE (Improvement in Medication Compliance through the Implementation of Personalized Nudges: the ENCOURAGE Trial)
o Co-Investigator
19. Cardiology Databases
o Co-Investigator
20. Return of Results (Return of Genetic Research Results Outcome Study)
o Co-Investigator
21. Familiality of Cardiovascular Disease (Familiality of Cardiovascular Disease using the Intermountain Genealogy Registry)
o Co-Investigator
22. Therapeutics for Inpatients with COVID-19 (TICO)
o Co-Investigator
23. Therapeutics for Severely Ill Inpatients with COVID-19 (TESICO)
o Co-Investigator
24. SomaSignal Study (Evaluating the impact of SomaSignal Tests on Medical Management and Change in Risk in Patients at Higher Risk of Cardiovascular Disease: A Feasibility and an Adaptive Implementation Study)
o Co-Investigator
25. VICTORION-INCEPTION (A randomized, controlled, multicenter, open-label trial comparing a hospital post-discharge care pathway involving aggressive LDL-C management that includes inclisiran with usual care versus usual care alone in patients with a recent acute coronary syndrome)
o Co-Investigator